HOME >> BIOLOGY >> NEWS
Children's Hospital researcher leads multipronged attack on infant leukemia

While survival rates for childhood leukemia have dramatically improved over the past 30 years, infants with this blood cancer continue to face difficult odds. Infant leukemia resists treatments such as chemotherapy and stem cell transplants that may be effective in older children, and infants are especially vulnerable to treatment side effects.

A new research effort led by a leukemia expert at The Children's Hospital of Philadelphia seeks to harness in-depth understanding of genes and molecular pathways to develop highly specific drugs designed to kill leukemia cells while causing few or no toxic effects on normal cells.

A five-year, $6.25 million Specialized Center of Research (SCOR) grant from the Leukemia & Lymphoma Society brings together a diverse study team of researchers from leading medical centers to develop innovative treatments for infant leukemia. "Our goal is to streamline advances in molecular medicine to find new treatment options," said Carolyn A. Felix, M.D., principal investigator of the SCOR grant. A pediatric oncologist at The Children's Hospital of Philadelphia, Dr. Felix also is a professor of Pediatrics at the University of Pennsylvania School of Medicine.

The society recently announced its grant award in targeted therapies for infant leukemia from its national office in White Plains, N.Y. The SCOR grant draws on research collaborators from a variety of disciplines to discover new approaches to treatment.

In addition to researchers from The Children's Hospital of Philadelphia and the University of Pennsylvania, the grant includes collaborators from the University of New Mexico, Johns Hopkins University, Stanford University and Tulane University.

Especially integral to this effort to advance new treatments from bench to bedside, the investigators also will work closely with the Children's Oncology Group, the cooperative clinical research organization of pediatric cancer centers throughout North
'"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
5-Dec-2006


Page: 1 2 3

Related biology news :

1. Doernbecher Childrens Hospital scientist earns coveted Javits award
2. NIH selects Childrens Hospital as Center of Excellence to train future generations of scientists
3. Childrens Hospital Oakland, Calif.s new iron regulation discovery
4. Childrens Hospital Oaklands new maternal diet study
5. Childrens Hospital and Research Center-Oakland presents a new maternal diet study
6. Childrens Hospital Boston presents at the 2006 American Academy of Pediatrics National Conference
7. Genetic research at Childrens Hospital of Pittsburgh reinforces theory of evolution
8. Childrens Hospital Boston presents at the 2006 Pediatric Academic Societies annual meeting
9. UCLA engineering and Mattel Childrens Hospital collaborate to develop childrens heart valve
10. Childrens Hospital Oakland scientist awarded seat on national scientific review board
11. Research center for National Childrens Study to be based in Queens

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... ... of chronic inflammatory and fibrotic diseases, today announced that Dr. Stacie Canan has ... Discovery. , Dr. Canan previously served as Executive Director of Global Health at ...
(Date:8/21/2020)... LEXINGTON, Mass. (PRWEB) , ... August 18, 2020 ... ... novel approaches to cell therapy, today announced that the U.S. Food and Drug ... evaluation of Sentien’s lead asset, SBI-101, for the treatment of severe COVID-19. Approval ...
(Date:8/12/2020)... ... 12, 2020 , ... Mosio recently announced its newly updated ... agencies of all sizes. With a focus on tracking symptoms and monitoring outbreaks ... care, Mosio helps public health departments automate communications and provide more personalized care ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. magazine today revealed ... in FDA compliance consulting has been named on its annual Inc. 5000 list, ... a unique look at the most successful companies within the American economy’s most ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... R3 Stem ... injections for only $3950. With 50 million stem cells total, patients may choose which ... cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... entered into a strategic partnership whereby Catalent will provide support for the development, ...
(Date:7/22/2020)... ... 2020 , ... Join experts from Reed Tech , Gary Saner, Sr. ... one hour live webinar on Thursday, August 13, 2020 at 11am EDT ... medical devices. Specifically, for medical devices, the NMPA has departments dealing with medical device ...
Breaking Biology Technology:
Cached News: